Is Nuveen ESG Mid-Cap Growth ETF ( NUMG ) a Strong ETF Right Now?
Smart Beta ETF report for ...
HOLX vs. IDXX: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Instruments stocks have likely encountered both Hologic ( HOLX Quick QuoteHOLX - ) and Idexx Laboratories ( IDXX Quick QuoteIDXX - ) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.
IDEXX Laboratories Stock Rallies 52.9% YTD: What's Behind the Drive?
IDXX soars 52.9% YTD, fueled by strong CAG Diagnostics growth, global expansion and rising demand for software solutions.
What Does the Market Think About IDEXX Laboratories? - IDEXX Laboratories ( NASDAQ:IDXX )
IDEXX Laboratories's ( NYSE: IDXX ) short interest as a percent of float has risen 3.64% since its last report. According to exchange reported data, there are now 2.12 million shares sold short, which is 3.42% of all regular shares that are available for trading.
Here's How Much $100 Invested In IDEXX Laboratories 20 Years Ago Would Be Worth Today - IDEXX Laboratories ( NASDAQ:IDXX )
IDEXX Laboratories IDXX has outperformed the market over the past 20 years by 3.35% on an annualized basis producing an average annual return of 12.2%. Currently, IDEXX Laboratories has a market capitalization of $53.12 billion.
Should Franklin U.S. Mid Cap Multifactor Index ETF ( FLQM ) Be on Your Investing Radar?
Style Box ETF report for ...
These Were the 3 Top-Performing Stocks in the Nasdaq-100 in August 2025
The month of August was unremarkable for your average Nasdaq-100 stock -- with a few notable exceptions. These three stocks enjoyed more than 20% price gains in an otherwise sleepy 30-day period.
Should You Add IDEXX Stock to Your Portfolio Right Now?
IDXX shows strong CAG Diagnostics growth, cloud software momentum and global expansion but faces solvency and macro risks.
Is Climb Bio, Inc. ( CLYM ) Stock Outpacing Its Medical Peers This Year?
Here is how Climb Bio, Inc. (CLYM) and Idexx Laboratories (IDXX) have performed compared to their sector so far this year.
MYGN Stock Might Gain on The Lancet Study Backing Precise MRD
Myriad Genetics' Precise MRD study in The Lancet shows ctDNA detection power in oligometastatic ccRCC, supporting oncology growth plans.
These Were the 5 Top-Performing Stocks in the S&P 500 in August 2025
One of these stocks could still be a good buy today thanks to an improving growth rate and a long history of strong financial results.
Why Is Idexx ( IDXX ) Down 0.4% Since Last Earnings Report?
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
These Were the 3 Top-Performing Stocks in the Nasdaq Composite in August 2025
The Nasdaq index finished the month positive but underperformed the S&P 500 and Dow Jones.
Idexx Laboratories ( IDXX ) Recently Broke Out Above the 20-Day Moving Average
Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
DGX Stock Gains Following a New Joint Venture With Corewell Health
Quest Diagnostics shares rise after forming a joint venture with Corewell Health to expand advanced lab services across Michigan.
If You Invested $1000 in Idexx Laboratories a Decade Ago, This is How Much It'd Be Worth Now
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Options Exercise: M. Anne Szostak At IDEXX Laboratories Realizes $951K - IDEXX Laboratories ( NASDAQ:IDXX )
Highlighted on August 26, it was unveiled in an SEC filing that Szostak, Board Member at IDEXX Laboratories IDXX, executed a significant transaction involving the exercise of company stock options. What Happened: Disclosed in a Form 4 filing on Tuesday with the U.S.
Should You Add IDEXX Stock to Your Portfolio Right Now?
IDXX gains from strong CAG Diagnostics growth and rising cloud software demand, but debt levels remain a concern for investors.
Is Encompass Health ( EHC ) Stock Outpacing Its Medical Peers This Year?
Here is how Encompass Health (EHC) and Idexx Laboratories (IDXX) have performed compared to their sector so far this year.
$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today - IDEXX Laboratories ( NASDAQ:IDXX )
IDEXX Laboratories IDXX has outperformed the market over the past 15 years by 10.51% on an annualized basis producing an average annual return of 23.32%. Currently, IDEXX Laboratories has a market capitalization of $51.97 billion.
3 Reasons Why Growth Investors Shouldn't Overlook Idexx ( IDXX )
Idexx (IDXX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
IDEXX Gains 56.2% in a Year: What's Driving the Rally?
IDXX shares surge 56.2% in a year, fueled by strong diagnostics growth, cloud software gains and an upbeat 2025 outlook.
Insulet Gains 77.2% in a Year: What's Driving the Rally?
PODD's 77.2% stock surge is fueled by Omnipod 5 expansion, global launches, strong Q2 profits and robust financial stability.
Should Boston Scientific Stock Be in Your Portfolio Right Now?
BSX's global expansion and MedSurg growth boost Q2 momentum, though currency and macro headwinds weigh on the same.
Here's Why Idexx Laboratories ( IDXX ) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Teleflex Stock Gains Following Barrigel's Launch in Japan
TFX stock jumps 3.7% after launching Barrigel in Japan, marking a milestone in its global expansion strategy.
PAHC Stock Up 76.4% in a Year: What's Driving the Rally?
Phibro Animal Health's 76.4% stock surge is fueled by strong sales recovery, global growth and a robust balance sheet.
Labcorp Debuts First FDA-Cleared Blood Test for Alzheimer's, Stock Up
LH launches the first FDA-cleared blood test for Alzheimer's, boosting access to early diagnosis and nudging its stock higher.
$1000 Invested In IDEXX Laboratories 15 Years Ago Would Be Worth This Much Today - IDEXX Laboratories ( NASDAQ:IDXX )
IDEXX Laboratories IDXX has outperformed the market over the past 15 years by 10.61% on an annualized basis producing an average annual return of 23.26%. Currently, IDEXX Laboratories has a market capitalization of $52.86 billion.
Here's How Much a $1000 Investment in Idexx Laboratories Made 10 Years Ago Would Be Worth Today
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
A Closer Look at IDEXX Laboratories's Options Market Dynamics - IDEXX Laboratories ( NASDAQ:IDXX )
Whales with a lot of money to spend have taken a noticeably bearish stance on IDEXX Laboratories. Looking at options history for IDEXX Laboratories IDXX we detected 8 trades. If we consider the specifics of each trade, it is accurate to state that 12% of the investors opened trades with bullish ...
Veterinary Diagnostics Market is expected to generate a revenue of USD 4.52 Billion by 2031, Globally, at 6.59% CAGR: Verified Market Research®
Lewes, Delaware, Aug. 11, 2025 ( GLOBE NEWSWIRE ) -- The Global Veterinary Diagnostics Market Size is projected to grow at a CAGR of 6.59% from 2024 to 2031, according to a new report published by Verified Market Research®.
Is Idexx ( IDXX ) a Solid Growth Stock? 3 Reasons to Think "Yes"
Idexx (IDXX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Here's Why Idexx Laboratories ( IDXX ) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Idexx Laboratories ( IDXX ) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Is the Market Bullish or Bearish on IDEXX Laboratories? - IDEXX Laboratories ( NASDAQ:IDXX )
IDEXX Laboratories's IDXX short percent of float has risen 3.9% since its last report. The company recently reported that it has 2.64 million shares sold short, which is 4.26% of all regular shares that are available for trading.
Tesla, Delta Air, IDEXX Laboratories And More On CNBC's 'Final Trades' - IDEXX Laboratories ( NASDAQ:IDXX ) , Delta Air Lines ( NYSE:DAL )
Jim Lebenthal names Delta Air Lines as his final trade. Bryn Talkington recommends sticking with Tesla. The next correction is closer than you think. Find out how Tom Gentile plans to trade it, live on Wednesday.
Here's How Much $1000 Invested In IDEXX Laboratories 20 Years Ago Would Be Worth Today - IDEXX Laboratories ( NASDAQ:IDXX )
IDEXX Laboratories IDXX has outperformed the market over the past 20 years by 4.25% on an annualized basis producing an average annual return of 12.73%. Currently, IDEXX Laboratories has a market capitalization of $55.35 billion.
Wayfair, CommScope Holding, Steelcase, IDEXX Laboratories And Other Big Stocks Moving Higher On Monday - Blade Air Mobility ( NASDAQ:BLDE ) , American Eagle Outfitters ( NYSE:AEO )
U.S. stocks were higher, with the Dow Jones index gaining around 400 points on Monday. Shares of Wayfair Inc. W rose sharply during Monday's session following better-than-expected second-quarter financial results. The e-commerce company reported adjusted earnings per share of 87 cents, beating ...
IDEXX Surpasses Earnings Expectations, Justifying Premium Valuation - IDEXX Laboratories ( NASDAQ:IDXX )
IDEXX Q2 earnings of $3.50 beat estimates; revenue rose 11% to $1.11 billion, driven by 11% growth in Companion Animal Group sales. Full-year EPS guidance raised to $12.40-$12.76 vs. $12.13 consensus; revenue forecast increased to $4.21-$4.28 billion.
IDEXX Stock Up on Q2 Earnings & Revenue Beat, Margins Expand
IDXX posts double-digit Q2 revenue growth, beats EPS estimates and lifts the full-year outlook as margins rise sharply.
Idexx ( IDXX ) Q2 Revenue Jumps 11%
Idexx Laboratories ( NASDAQ:IDXX ) , a leading provider of veterinary diagnostics and software, released its second-quarter earnings on August 4, 2025. The company's update for the quarter highlighted much stronger than anticipated financial results, led by rapid adoption of new diagnostic ...
Idexx Laboratories ( IDXX ) Tops Q2 Earnings and Revenue Estimates
Idexx (IDXX) delivered earnings and revenue surprises of +9.67% and +4.01%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Integra LifeSciences ( IART ) Beats Q2 Earnings and Revenue Estimates
Integra (IART) delivered earnings and revenue surprises of +4.65% and +5.05%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Idexx ( IDXX ) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
Beyond analysts' top-and-bottom-line estimates for Idexx (IDXX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
AxoGen ( AXGN ) Earnings Expected to Grow: Should You Buy?
AxoGen (AXGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Peering Into IDEXX Laboratories's Recent Short Interest - IDEXX Laboratories ( NASDAQ:IDXX )
IDEXX Laboratories's IDXX short percent of float has risen 3.9% since its last report. The company recently reported that it has 2.64 million shares sold short, which is 4.26% of all regular shares that are available for trading.
Idexx Laboratories ( IDXX ) Earnings Expected to Grow: Should You Buy?
Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IDEXX to Release Q2 Earnings: What's in Store for the Stock?
IDXX eyes a Q2 earnings jump with CAG growth, global pricing gains, and momentum in water and software segments.
Should You Invest in the First Trust Water ETF ( FIW ) ?
Sector ETF report for ...
